Science Corporation has released promising preliminary data from a clinical trial for a retina implant that partially restored vision in people with age-related macular degeneration. The technology involves an implant, glasses with a camera, and a pocket computer that mimics the process of vision formation. The study showed significant improvements in visual acuity in participants after twelve months of use. Although there are some caveats, experts are impressed with the technology’s potential. The company plans to release a more comprehensive analysis of the trial data and seek regulatory approval. This groundbreaking research could revolutionize the treatment of severe vision loss.
Source link
Vision restored in macular degeneration patients
